drugset / Trial / NCT04282928

Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Viral Pneumonian

NCT04282928

Phase 1 Unknown 40 enrolled Shanghai East Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this clinical study is to answer the questions: 1. Is the proposed intervention safe? 2. Is the proposed intervention effective in improving the health of subjects with severe viral pneumonia?

Timeline

Start
2020-02
Primary completion
2021-01
Completion
2021-03

Drugs

EvaluationDrugModalityDoseRoute
Subject human umbilical cord mesenchymal stem cells Cell therapy 1e+06 cells/kg Intravenous

Indications